1.
Cost-Effectiveness of Disease Management Programs for Cardiovascular Risk and COPD in The Netherlands
2.
Cost Effectiveness of the Angiotensin Receptor Neprilysin Inhibitor Sacubitril/Valsartan for Patients with Chronic Heart Failure and Reduced Ejection Fraction in the Netherlands: A...
3.
4.
5.
Cost-Effectiveness of Early Assisted Discharge for COPD Exacerbations in The Netherlands